Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285399
Max Phase: Preclinical
Molecular Formula: C30H48O5
Molecular Weight: 488.71
Associated Items:
ID: ALA5285399
Max Phase: Preclinical
Molecular Formula: C30H48O5
Molecular Weight: 488.71
Associated Items:
Canonical SMILES: C/C=C(\C)[C@H]1OC(=O)[C@H](C)[C@@H](O)/C(C)=C/C=C/[C@H](C)C/C(C)=C/[C@@H](C)[C@H](O)C[C@@H](O)/C(C)=C/[C@H]1C
Standard InChI: InChI=1S/C30H48O5/c1-10-20(4)29-24(8)16-23(7)27(32)17-26(31)22(6)15-19(3)14-18(2)12-11-13-21(5)28(33)25(9)30(34)35-29/h10-13,15-16,18,22,24-29,31-33H,14,17H2,1-9H3/b12-11+,19-15+,20-10+,21-13+,23-16+/t18-,22+,24+,25+,26+,27+,28-,29+/m0/s1
Standard InChI Key: GNJRQPNRGTYFPA-GFZLUUDSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 488.71 | Molecular Weight (Monoisotopic): 488.3502 | AlogP: 5.68 | #Rotatable Bonds: 1 |
Polar Surface Area: 86.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.91 | CX Basic pKa: | CX LogP: 5.32 | CX LogD: 5.32 |
Aromatic Rings: 0 | Heavy Atoms: 35 | QED Weighted: 0.33 | Np Likeness Score: 2.17 |
1. Lu S, Zhou T, Fukaya K, Harunari E, Oku N, Urabe D, Igarashi Y.. (2022) Krasilnikolides A and B and Detalosylkrasilnikolide A, Cytotoxic 20-Membered Macrolides from the Genus Krasilnikovia: Assignment of Anomeric Configuration by J-Based Configuration Analysis., 85 (12.0): [PMID:36482689] [10.1021/acs.jnatprod.2c00781] |
Source(1):